Jeremy Green, 10% Owner at Syros Pharmaceuticals, Inc. (SYRS), bought 432,746 shares at $12.50 ($5.4M) on 2016-07-06, disclosed to the SEC on 2016-07-07.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.50 | 9,373 | $117K | 2.2% |
| 2 | $12.50 | 104,670 | $1.3M | 24.2% |
| 3 | $12.50 | 144,383 | $1.8M | 33.4% |
| 4 | $12.50 | 174,320 | $2.2M | 40.3% |
| Total | $12.50 avg | 432,746 | $5.4M | 100% |
| Filing → |
| ADCT | BUY | 2024-12-13 | $419K | — | Filing → |
| STTK | BUY | 2024-12-06 | $333K | — | Filing → |
| STTK | SELL | 2024-12-06 | $333K | — | Filing → |